New PET tracer aims to spot Parkinson's protein in living brains
NCT ID NCT06891703
First seen Nov 19, 2025 · Last updated May 09, 2026 · Updated 23 times
Summary
This early-phase study tests whether a new radioactive tracer called [18F]ACI-15916 can safely and reliably detect harmful alpha-synuclein protein clumps in the brain using PET scans. About 46 people—including healthy volunteers and those with suspected Parkinson's disease, multiple system atrophy, or Lewy body dementia—will receive the tracer and undergo brain imaging. The goal is to improve diagnosis and understanding of these diseases, not to treat them.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSON'S DISEASE (PD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Karolinska Institutet
RECRUITINGSolna, Sweden
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.